Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries

The Lancet Global Health

Volumn 6, Issue 5, 2018, Pages e555-e567

  Zeng, Hongmei ^a   Chen, Wanqing ^a   Zheng, Rongshou ^a   Zhang, Siwei ^a   Ji, John S ^b,c   Zou, Xiaonong ^a   Xia, Changfa ^a   Sun, Kexin ^a   Yang, Zhixun ^a   Li, He ^a   Wang, Ning ^d   Han, Renqiang ^e   Liu, Shuzheng ^f   Li, Huizhang ^g   Mu, Huijuan ^h   He, Yutong ⁱ   Xu, Yanjun ^j   Fu, Zhentao ^k   Zhou, Yan ^l   Jiang, Jie ^m   Yang, Yanlei ⁿ   Chen, Jianguo ^o   Wei, Kuangrong ^p   Fan, Dongmei ^q   Wang, Jian ^r   Fu, Fangxian ^s   Zhao, Deli ^t   Song, Guohui ^u   Chen, Jianshun ^v   Jiang, Chunxiao ^w   Zhou, Xin ^x   Gu, Xiaoping ^y   Jin, Feng ^z   Li, Qilong ^aa   Li, Yanhua ^ab   Wu, Tonghao ^ac   Yan, Chunhua ^ad   Dong, Jianmei ^ae   Hua, Zhaolai ^af   Baade, Peter ^ag   Bray, Freddie ^ah   Jemal, Ahmedin ^ai   Yu, Xue Qin ^aj   He, Jie ^a   more..

^a CANCER HOSPITAL   (China)

^b DUKE KUNSHAN UNIVERSITY   (China)

^c DUKE UNIVERSITY   (United States)

^d PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^e Jiangsu Province   (China)

^f Henan Cancer Hospital   (China)

^g Zhejiang Cancer Center Cancer Hospital   (China)

^h Liaoning Ctr for Dis Contr/Prev   (China)

ⁱ HEBEI MEDICAL UNIVERSITY   (China)

^j GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^k Shandong Center for Disease Control and Prevention   (China)

^l FUJIAN MEDICAL UNIVERSITY   (China)

^m Dalian Cancer Registry Dalian Center for Disease Control and Prevention   (China)

ⁿ Haimen Cancer Registry Haimen Center for Disease Control and Prevention   (China)

^o QIDONG LIVER CANCER INSTITUTE   (China)

^p ZHONGSHAN PEOPLE S HOSPITAL   (China)

^q Taixing Cancer Registry Taixing Center for Disease Control and Prevention   (China)

^r Jianhu Cancer Registry Jianhu Center for Disease Control and Prevention   (China)

^s Linzhou Cancer Hospital   (China)

^t Feicheng People's Hospital   (China)

^u Cixian Cancer Registry Cixian Institute for Cancer Prevention and Control   (China)

^v Changle Cancer Registry Changle Institute for Cancer Prevention and Control   (China)

^w Haining Cancer Registry Haining Institute for Cancer Prevention and Control   (China)

^x Jintan Cancer Registry Jintan Center for Disease Control and Prevention   (China)

^y Dafeng Cancer Registry Dafeng Center for Disease Control and Prevention   (China)

^z Ganyu Cancer Registry Ganyu Center for Disease Control and Prevention   (China)

^aa Jiashan Cancer Registry Jiashan Institute for Cancer Prevention and Control   (China)

^ab Sihui Cancer Registry   (China)

^ac Donghai Cancer Registry Donghai Center for Disease Control and Prevention   (China)

^ad Guanyun Cancer Registry Guanyun Center for Disease Control and Prevention   (China)

^ae Lianyungang Cancer Registry Lianyungang Center for Disease Control and Prevention   (China)

^af Yangzhong Cancer Registry Yangzhong Center for Disease Control and Prevention   (China)

^ag CANCER COUNCIL QUEENSLAND   (Australia)

^ah INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ai AMERICAN CANCER SOCIETY   (United States)

^aj CANCER RESEARCH DIVISION   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE CANCER; BRAIN CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CHINA; DIGESTIVE SYSTEM CANCER; FEMALE; FEMALE GENITAL TRACT CANCER; HEMATOPOIETIC SYSTEM MALIGNANCY; HUMAN; ICD-10; INFANT; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; NEOPLASM; NEWBORN; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; RURAL AREA; SKIN CANCER; THYROID CANCER; URBAN AREA; VERY ELDERLY; CANCER SURVIVOR; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; REGISTER; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANCER SURVIVORS; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; SURVIVAL RATE; YOUNG ADULT;

EID: 85045210321     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(18)30127-X     Document Type: Article

References (44)

1. Torre, LA, Bray, F, Siegel, RL, Ferlay, J, Lortet-Tieulent, J, Jemal, A, Global cancer statistics, 2012. CA Cancer J Clin 65 (2015), 87–108.
2. Ferlay, J, Soerjomataram, I, Dikshit, R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
3. Zhou, M, Wang, H, Zhu, J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387 (2016), 251–272.
4. Yang, G, Wang, Y, Zeng, Y, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 381 (2013), 1987–2015.
5. Zeng, H, Zheng, R, Guo, Y, et al. Cancer survival in China, 2003–2005: a population-based study. Int J Cancer 136 (2015), 1921–1930.
6. Lachmann, P, Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK. Lancet, 377, 2011, 1149.
7. The State Council of the People's Republic of China. State Council issues plan to prevent chronic diseases. http://english.gov.cn/policies/latest_releases/2017/02/14/content_281475567482818.htm (accessed Jan 15, 2018).
8. The State Council of the People's Republic of China. China eyes life expectancy of 79 in 2030 health plan. http://english.gov.cn/policies/latest_releases/2016/10/25/content_281475475062678.htm (accessed Jan 15, 2018).
9. National Health and Family Planning Commission of the People's Republic of China. China's cancer prevention and treatment three-year action plan. http://en.nhfpc.gov.cn/2016-01/08/c_68740.htm, 2015–2017 (accessed Jan 15, 2018).
10. Zou, XN, Epidemic trend, screening, and early detection and treatment of cancer in Chinese population. Cancer Biol Med 14 (2017), 50–59.
11. Goss, PE, Strasser-Weippl, K, Lee-Bychkovsky, BL, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 15 (2014), 489–538.
12. Chen, W, Zheng, R, Baade, PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 66 (2016), 115–132.
13. He, J, Chen, W, Chinese guideline for cancer registration. 2016, People's Medical Publishing House, Beijing.
14. Ferlay, J, Burkhard, C, Whelan, S, Parkin, DM, Check and conversion programs for cancer registries. (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42, 2005. 2005, IARC Press, Lyon.
15. Ederer, F, Heise, H, Instructions to IBM650 Programmers in processing survival computations. 1959, National Cancer Institute, Bethesda, MD.
16. Eldandt–Johnson, RC, Johnson, NL, Survival models and data analysis (Wiley series in probability and mathematical statistics). 1980, Wiley, Indianapolis.
17. Corazziari, I, Quinn, M, Capocaccia, R, Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40 (2004), 2307–2316.
18. Greenwood, M, The natural duration of cancer. 1926, HMSO, London.
19. Brenner, H, Gefeller, O, Hakulinen, T, Period analysis for ‘up-to-date’ cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 40 (2004), 326–335.
20. Brenner, H, Rachet, B, Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 40 (2004), 2494–2501.
21. Rachet, B, Ellis, L, Maringe, C, et al. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer 103 (2010), 446–453.
22. Rachet, B, Maringe, C, Nur, U, et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 10 (2009), 351–369.
23. Woods, LM, Rachet, B, Cooper, N, Coleman, MP, Predicted trends in long-term breast cancer survival in England and Wales. Br J Cancer 96 (2007), 1135–1138.
24. China Statistical Yearbook 2015. 2015, China Statistics Press, Beijing.
25. Cai, Y, Xue, M, Chen, W, et al. Expenditure of hospital care on cancer in China, from 2011 to 2015. Chin J Cancer Res 29 (2017), 253–262.
26. Karanikolos, M, Ellis, L, Coleman, MP, McKee, M, Health systems performance and cancer outcomes. J Natl Cancer Inst Monogr 2013 (2013), 7–12.
27. Dickman, PW, Adami, HO, Interpreting trends in cancer patient survival. J Intern Med 260 (2006), 103–117.
28. Black, WC, Welch, HG, Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 328 (1993), 1237–1243.
29. Etzioni, R, Penson, DF, Legler, JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94 (2002), 981–990.
30. Yan, HX, Pang, P, Wang, FL, et al. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000–2013 in China: a retrospective study. Sci Rep, 7, 2017, 15832.
31. Meng, Q, Xu, L, Zhang, Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet 379 (2012), 805–814.
32. Dong, H, Duan, S, Bogg, L, et al. The impact of expanded health system reform on governmental contributions and individual copayments in the new Chinese rural cooperative medical system. Int J Health Plann Manage 31 (2016), 36–48.
33. Liu, X, Wong, H, Liu, K, Outcome-based health equity across different social health insurance schemes for the elderly in China. BMC Health Serv Res, 16, 2016, 9.
34. Quaresma, M, Coleman, MP, Rachet, B, 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study. Lancet 385 (2015), 1206–1218.
35. Jansen, L, Castro, FA, Gondos, A, et al. Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer 136 (2015), 2649–2658.
36. Zeng, C, Wen, W, Morgans, AK, Pao, W, Shu, XO, Zheng, W, Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncol 1 (2015), 88–96.
37. Nur, U, Lyratzopoulos, G, Rachet, B, Coleman, MP, The impact of age at diagnosis on socioeconomic inequalities in adult cancer survival in England. Cancer Epidemiol 39 (2015), 641–649.
38. Brenner, H, Hakulinen, T, Implications of incomplete registration of deaths on long-term survival estimates from population-based cancer registries. Int J Cancer 125 (2009), 432–437.
39. Yang, L, Wang, N, Zhu, WX, Xing, XM, Sun, TT, The analysis of the active follow-up study of registered cancer patients between 2002 and 2005 in urban areas of Beijing. Chin J Prev Med 46 (2012), 604–606.
40. Allemani, C, Weir, HK, Carreira, H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385 (2015), 977–1010.
41. De Angelis, R, Sant, M, Coleman, MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5— a population-based study. Lancet Oncol 15 (2014), 23–34.
42. Howlader, N, Noone, AM, Krapcho, M, et al. SEER Cancer Statistics Review, 1975–2014. https://seer.cancer.gov/csr/1975_2014/, April 2017 (accessed April 20, 2017).
43. Australian Government. Cancer in Australia. https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2017/contents/table-of-contents, 2017 (accessed Sept 1, 2017).
44. Coleman, MP, Cancer survival: global surveillance will stimulate health policy and improve equity. Lancet 383 (2014), 564–573.